Статті в журналах з теми "Melanoma Screening Trial (MST)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Melanoma Screening Trial (MST)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Elwood, J. M. "Screening for Melanoma and Options For-Its Evaluation." Journal of Medical Screening 1, no. 1 (January 1994): 22–38. http://dx.doi.org/10.1177/096914139400100107.
Повний текст джерелаDjavid, Amir Reza, Connor Stonesifer, Benjamin T. Fullerton, Samuel W. Wang, Marlene A. Tartaro, Bradley D. Kwinta, Joseph M. Grimes, Larisa J. Geskin, and Yvonne M. Saenger. "Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence." Cancers 13, no. 19 (September 30, 2021): 4914. http://dx.doi.org/10.3390/cancers13194914.
Повний текст джерелаPrimiero, Clare Amy, Aideen M. McInerney-Leo, Brigid Betz-Stablein, David C. Whiteman, Louisa Gordon, Liam Caffery, Joanne F. Aitken, et al. "Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial." BMJ Open 9, no. 11 (November 2019): e032969. http://dx.doi.org/10.1136/bmjopen-2019-032969.
Повний текст джерелаMatias, Mariana, Jacinta O. Pinho, Maria João Penetra, Gonçalo Campos, Catarina Pinto Reis, and Maria Manuela Gaspar. "The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval." Cells 10, no. 11 (November 9, 2021): 3088. http://dx.doi.org/10.3390/cells10113088.
Повний текст джерелаColman, Howard, Ken Boucher, Chris Stehn, David Kircher, and Sheri Holmen. "THER-07. DEVELOPMENT OF A NEW MOLECULAR PREDICTOR FOR RISK OF BRAIN METASTASES AND EFFICACY OF TARGETED THERAPY IN MELANOMA." Neuro-Oncology Advances 1, Supplement_1 (August 2019): i12. http://dx.doi.org/10.1093/noajnl/vdz014.050.
Повний текст джерелаSarasamma, Sreeja, Yu-Heng Lai, Sung-Tzu Liang, Kechun Liu, and Chung-Der Hsiao. "The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities." International Journal of Molecular Sciences 19, no. 12 (December 7, 2018): 3929. http://dx.doi.org/10.3390/ijms19123929.
Повний текст джерелаKok, Peey-Sei, Won-Hee Yoon, Sally Lord, Ian Marschner, Michael Friedlander, and Chee Khoon Lee. "Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-Analysis." JCO Precision Oncology, no. 5 (July 2021): 1151–59. http://dx.doi.org/10.1200/po.21.00108.
Повний текст джерелаBrastianos, Priscilla Kaliopi, Erin Twohy, Carey K. Anders, A. John Iafrate, Peter A. Kaufman, Justine Vanessa Cohen, Rebecca Suk Heist, et al. "Alliance A071701: Genomically guided treatment trial in brain metastases." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): TPS2573. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps2573.
Повний текст джерелаShah, Payal D., Alexander Chan Chi Huang, Xiaowei Xu, Paul J. Zhang, Robert Orlowski, Tina Matlawski, Joanne Shea, et al. "Phase I trial of autologous cMET-directed CAR-t cells administered intravenously in patients with melanoma & breast carcinoma." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 10035. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.10035.
Повний текст джерелаSimonelli, Matteo, Emiliano Calvo, Diwakar Davar, Jason Melear, Donald Richards, Matthew Dallos, Martin Gutierrez, et al. "Abstract CT119: A randomized, double-blind phase 2 evaluation of the anti-IL-8 monoclonal antibody BMS-986253 + nivolumab + ipilimumab vs nivolumab + ipilimumab in patients with advanced melanoma that progressed on/after anti-PD-(L)1 therapy." Cancer Research 82, no. 12_Supplement (June 15, 2022): CT119. http://dx.doi.org/10.1158/1538-7445.am2022-ct119.
Повний текст джерелаSamlowski, Wolfram E., James Moon, Merle Witter, Michael B. Atkins, John M. Kirkwood, Megan Othus, Antoni Ribas, Vernon K. Sondak, and Lawrence E. Flaherty. "CNS metastases as a site of progression on SWOG intergroup study S0008: A phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 (BCT) versus high-dose interferon (HDI) in patients with high-risk melanoma." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 8527. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8527.
Повний текст джерелаIglesias, Jose Luis, Radha Prathikanti, Bo Ma, Paulette Mattson, Deb Kedrowski, Jamie Lowe, Nandita Bose, et al. "A multicenter, open-label, phase II study of PGG beta-glucan and pembrolizumab in patients (pts) with advanced melanoma (MEL) following progression on treatment with checkpoint inhibitors (CPI) or triple negative breast cancer (TNBC) failing front-line chemotherapy for metastatic disease." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): TPS3105. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps3105.
Повний текст джерелаLam, Megan, Justin Di Lu, Levi Elhadad, Cathryn Sibbald, and Raed Alhusayen. "Common Dermatologic Disorders in Down Syndrome: Systematic Review." JMIR Dermatology 5, no. 1 (February 8, 2022): e33391. http://dx.doi.org/10.2196/33391.
Повний текст джерелаHamid, Omid, Ding Wang, Tae Min Kim, Sang-We Kim, Nehal J. Lakhani, Melissa Lynne Johnson, Roman Groisberg, et al. "Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 9515. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.9515.
Повний текст джерелаShen, Yu, and Marvin Zelen. "Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations." Journal of Clinical Oncology 19, no. 15 (August 1, 2001): 3490–99. http://dx.doi.org/10.1200/jco.2001.19.15.3490.
Повний текст джерелаSharma, Sombeer, Aakash Deep, and Arun K. Sharma. "Current Treatment for Cervical Cancer: An Update." Anti-Cancer Agents in Medicinal Chemistry 20, no. 15 (October 27, 2020): 1768–79. http://dx.doi.org/10.2174/1871520620666200224093301.
Повний текст джерелаWang, Tianjiao, Jean-Marc Navenot, Stavros Rafail, Mark Carroll, Ruoxi Wang, Cheryl McAlpine, Swethajit Biswas, et al. "Abstract LB001: Identifying MAGE-A4-positive tumors for SPEAR T-cell therapies in HLA-A*02-eligible patients." Cancer Research 82, no. 12_Supplement (June 15, 2022): LB001. http://dx.doi.org/10.1158/1538-7445.am2022-lb001.
Повний текст джерелаDavar, Diwakar, Matteo Simonelli, Martin Gutierrez, Emiliano Calvo, Jason Melear, Sarina Piha-Paul, Donald Richards, et al. "394 Interleukin-8–neutralizing monoclonal antibody BMS-986253 plus nivolumab (NIVO) in biomarker-enriched, primarily anti–PD-(L)1–experienced patients with advanced cancer: initial phase 1 results." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A419. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0394.
Повний текст джерелаHellinen, Laura, Sina Bahrpeyma, Anna-Kaisa Rimpelä, Marja Hagström, Mika Reinisalo, and Arto Urtti. "Microscale Thermophoresis as a Screening Tool to Predict Melanin Binding of Drugs." Pharmaceutics 12, no. 6 (June 16, 2020): 554. http://dx.doi.org/10.3390/pharmaceutics12060554.
Повний текст джерелаAitken, J. F., J. M. Elwood, J. B. Lowe, D. W. Firman, K. P. Balanda, and I. T. Ring. "A randomised trial of population screening for melanoma." Journal of Medical Screening 9, no. 1 (March 2002): 33–37. http://dx.doi.org/10.1136/jms.9.1.33.
Повний текст джерелаTarhini, Ahmad A., Paul Lorigan, and Sancy Leachman. "Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy." American Society of Clinical Oncology Educational Book, no. 37 (May 2017): 651–60. http://dx.doi.org/10.1200/edbk_174930.
Повний текст джерелаMehta, M. P., A. Dagnault, P. Chabot, J. Suh, E. Chang, M. Fortin, R. Timmerman, J. Grecula, L. Eubank, and M. F. Renschler. "Identification of occult brain metastases amenable to stereotactic radiosurgery by motexafin gadolinium (MGd) based treatment planning MRI: Results of a phase II trial of MGd and whole brain radiotherapy (WBRT) with stereotactic radiosurgery (SRS)." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 2037. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.2037.
Повний текст джерелаShi, Yuankai, Suxia Luo, Huan Zhou, Shengyu Zhou, Shan An, Zishu Wang, Sheng Yang, Ning Li, Xiaoli Li, and Xinyi Yang. "Phase I study of LBL-007, a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody in patients with advanced solid tumors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 2523. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.2523.
Повний текст джерелаSharman, Jeff Porter, Jerome H. Goldschmidt, John M. Burke, Beth A. Hellerstedt, Kristi McIntyre, Christopher A. Yasenchak, Thomas E. Boyd, et al. "CD30 expression in nonlymphomatous malignancies." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 3069. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.3069.
Повний текст джерелаCorcoran, Ryan Bruce, Gerald Steven Falchook, Jeffrey R. Infante, Omid Hamid, Wells A. Messersmith, Adil Daud, Eunice Lee Kwak, et al. "Pharmacodynamic and efficacy analysis of the BRAF inhibitor dabrafenib (GSK436) in combination with the MEK inhibitor trametinib (GSK212) in patients with BRAFV600 mutant colorectal cancer (CRC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 3507. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3507.
Повний текст джерелаCust, A. E., J. F. Aitken, P. D. Baade, D. C. Whiteman, H. P. Soyer, and M. Janda. "Why a randomized melanoma screening trial may be a good idea." British Journal of Dermatology 179, no. 5 (September 20, 2018): 1227–28. http://dx.doi.org/10.1111/bjd.17089.
Повний текст джерелаHyde, Mark A., Douglas Grossman, Yelena P. Wu, Saundra Buys, Lisa H. Gren, and Mia Hashibe. "Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients." Journal of the American Academy of Physician Assistants 33, no. 6 (June 2020): 35–41. http://dx.doi.org/10.1097/01.jaa.0000662388.18867.42.
Повний текст джерелаMaeda, Tetsuo, Ukihide Tateishi, Shigenobu Suzuki, Yasuaki Arai, E. Edmund Kim, and Kazuro Sugimura. "Magnetic Resonance Screening Trial for Hepatic Metastasis in Patients with Locally Controlled Choroidal Melanoma." Japanese Journal of Clinical Oncology 37, no. 4 (April 1, 2007): 282–86. http://dx.doi.org/10.1093/jjco/hym018.
Повний текст джерелаClouthier, Derek L., Cindy Yang, Scott Lien, Diana Gray, Ilaria Colombo, Stephanie Lheureux, Jeremy Howard Lewin, et al. "A technical feasibility report on correlative studies from the investigator-initiated phase II study of pembrolizumab (Pembro) immunological response evaluation (INSPIRE)." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 11607. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.11607.
Повний текст джерелаZhang, Hongjun, Xiangnan Liu, Yong’an Chen, Rui Xu, and Shengli He. "KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma." BioMed Research International 2022 (September 28, 2022): 1–9. http://dx.doi.org/10.1155/2022/1556485.
Повний текст джерелаUrosevic, V., Ph Chollet, A. Adenis, J. Chauvergne, P. Fargeot, H. Roche, P. Kerbrat, M. A. Lentz, P. Fumoleau, and B. Chevallier. "Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group." European Journal of Cancer 32, no. 1 (January 1996): 181–82. http://dx.doi.org/10.1016/0959-8049(95)00473-4.
Повний текст джерелаMarkham, Merry Jennifer, Kerri Wachter, Neeraj Agarwal, Monica M. Bertagnolli, Susan Marina Chang, William Dale, Catherine S. M. Diefenbach, et al. "Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology." Journal of Clinical Oncology 38, no. 10 (April 1, 2020): 1081. http://dx.doi.org/10.1200/jco.19.03141.
Повний текст джерелаHanrahan, P. F., C. A. D’Este, S. W. Menzies, T. Plummer, and P. Hersey. "A randomised trial of skin photography as an aid to screening skin lesions in older males." Journal of Medical Screening 9, no. 3 (September 1, 2002): 128–32. http://dx.doi.org/10.1136/jms.9.3.128.
Повний текст джерелаThompson, John F., Mario Santinami, Thomas Jouary, Eugeny Levchenko, Bernard Mark Smithers, Laurent Mortier, Jean Jacques Grob, et al. "MAGE-A3 expression in patients screened for the DERMA trial: A phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanoma." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 8559. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8559.
Повний текст джерелаLyle, Megan, and Georgina V. Long. "Diagnosis and Treatment ofKIT-Mutant Metastatic Melanoma." Journal of Clinical Oncology 31, no. 26 (September 10, 2013): 3176–81. http://dx.doi.org/10.1200/jco.2013.50.4662.
Повний текст джерелаMarshall, Ernest, Chris Romaniuk, Paula Ghaneh, Helen Wong, Marie McKay, Mona Chopra, Sarah Coupland, and Bertil Damato. "High-risk uveal melanoma: A prospective study evaluating the role of magnetic resonance imaging of the liver." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 8564. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8564.
Повний текст джерелаRobinson, June K., Namita Jain, Ashfaq A. Marghoob, William McGaghie, Michael MacLean, Pedram Gerami, Brittney Hultgren, Rob Turrisi, Kimberly Mallett, and Gary J. Martin. "A Randomized Trial on the Efficacy of Mastery Learning for Primary Care Provider Melanoma Opportunistic Screening Skills and Practice." Journal of General Internal Medicine 33, no. 6 (February 5, 2018): 855–62. http://dx.doi.org/10.1007/s11606-018-4311-3.
Повний текст джерелаZhu, Lucía, Natalia Yebra, Diana Retana, Carmen Blanco-Aparicio, Sonia Martínez, Riccardo Soffietti, Luca Bertero, et al. "42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM." Neuro-Oncology Advances 2, Supplement_2 (August 2020): ii8. http://dx.doi.org/10.1093/noajnl/vdaa073.030.
Повний текст джерелаLupo-Stanghellini, Maria Teresa, Giacomo Oliveira, Raffaella Greco, Luca Vago, Attilio Bondanza, Fabio Ciceri, Claudio Bordignon, and Chiara Bonini. "TK-Cells Safety and Efficacy in Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Clinical and Molecular Assessment in 128 Treated Patients." Blood 120, no. 21 (November 16, 2012): 3061. http://dx.doi.org/10.1182/blood.v120.21.3061.3061.
Повний текст джерелаOhmoto, Akihiro, Shinichi Yachida, and Chigusa Morizane. "Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer." International Journal of Molecular Sciences 20, no. 3 (January 29, 2019): 561. http://dx.doi.org/10.3390/ijms20030561.
Повний текст джерелаPrimiero, Clare A., Anna Finnane, Tatiane Yanes, Betsy Peach, H. Peter Soyer, and Aideen M. McInerney-Leo. "Protocol to evaluate a pilot program to upskill clinicians in providing genetic testing for familial melanoma." PLOS ONE 17, no. 12 (December 7, 2022): e0275926. http://dx.doi.org/10.1371/journal.pone.0275926.
Повний текст джерелаAnderson, Steven, Kenneth J. Bloom, Dino U. Vallera, Josef Rueschoff, Cliff Meldrum, Robert Schilling, Barbara Kovach, et al. "Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma." Archives of Pathology & Laboratory Medicine 136, no. 11 (November 1, 2012): 1385–91. http://dx.doi.org/10.5858/arpa.2011-0505-oa.
Повний текст джерелаLocke, Darren, Steven Bernstein, Frank Lynch, Koushan Siami-Namini, Jackie M. Walling, Thomas Yonker, and Geoffrey Yarranton. "An IHC Screen For EphA3 Positive FFPE Tumors." Blood 122, no. 21 (November 15, 2013): 4965. http://dx.doi.org/10.1182/blood.v122.21.4965.4965.
Повний текст джерелаMaller, Bradley, Vani Nath Simmons, Margaret M. Byrne, and Tawee Tanvetyanon. "Outcomes of lung cancer screening among cancer survivors: An NCCN institution experience." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 1595. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1595.
Повний текст джерелаSnoswell, Centaine L., Jennifer A. Whitty, Liam J. Caffery, Lois J. Loescher, Nicole Gillespie, and Monika Janda. "Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia." Journal of Telemedicine and Telecare 24, no. 10 (October 22, 2018): 683–89. http://dx.doi.org/10.1177/1357633x18799582.
Повний текст джерелаHay, Jennifer L., Kimberly A. Kaphingst, David Buller, Elizabeth Schofield, Kirsten Meyer White, Andrew Sussman, Dolores Guest, et al. "Behavioral and Psychological Outcomes Associated with Skin Cancer Genetic Testing in Albuquerque Primary Care." Cancers 13, no. 16 (August 12, 2021): 4053. http://dx.doi.org/10.3390/cancers13164053.
Повний текст джерелаJohnson, Laura A., Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, et al. "Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen." Blood 114, no. 3 (July 16, 2009): 535–46. http://dx.doi.org/10.1182/blood-2009-03-211714.
Повний текст джерелаButow, Phyllis N., Jane Turner, Jemma Gilchrist, Louise Sharpe, Allan Ben Smith, Joanna E. Fardell, Stephanie Tesson, et al. "Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence." Journal of Clinical Oncology 35, no. 36 (December 20, 2017): 4066–77. http://dx.doi.org/10.1200/jco.2017.73.1257.
Повний текст джерелаAthavale, Ambarish M. "Capsule Commentary on Robinson et al.: A Randomized Trial on the Efficacy of Mastery Learning on Primary Care Providers’ Melanoma Opportunistic Screening Skills and Practice." Journal of General Internal Medicine 33, no. 6 (February 15, 2018): 946. http://dx.doi.org/10.1007/s11606-018-4360-7.
Повний текст джерелаAmin, Asim, Mohammed M. Milhem, Georgina V. Long, Christopher J. Hoimes, Theresa Michelle Medina, Robert Martin Conry, Christopher D. Lao, et al. "Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced/metastatic melanoma resistant to anti-PD-1/PD-L1 therapy." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 9555. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.9555.
Повний текст джерела